FDG-PET for response assessment of malignant lymphoma

研究成果: Review article査読

抄録

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is a promising functional imaging test for patients with malignant lymphoma (ML) , and has gained wide usage during the last decade. In 2007, an International Harmonization Project (IHP) proposed revised response criteria for evaluating therapy responses in ML and consensus recommendations of FDG-PET for this purpose. The relevance of the response criteria and consensus recommendations should be validated in prospective clinical trials. Clinicians should utilize them cautiously in clinical practice because clinical data on decision making depending on these guidelines are still limited.

本文言語English
ページ(範囲)418-424
ページ数7
ジャーナルJapanese Journal of Clinical Radiology
52
3
出版ステータスPublished - 13-04-2007
外部発表はい

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

フィンガープリント 「FDG-PET for response assessment of malignant lymphoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル